These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10714960)

  • 1. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Boccuni P; Del Vecchio L; Di Noto R; Rotoli B
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):25-43. PubMed ID: 10714960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of paroxysmal nocturnal hemoglobinuria.
    Rosti V
    Haematologica; 2000 Jan; 85(1):82-7. PubMed ID: 10629597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria.
    Colden MA; Kumar S; Munkhbileg B; Babushok DV
    Front Immunol; 2021; 12():830172. PubMed ID: 35154088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.
    Shingai N; Mizumaki H; Najima Y; Yamada Y; Tran DC; Haraguchi K; Toya T; Okuyama Y; Doki N; Nannya Y; Ogawa S; Nakao S
    Front Immunol; 2023; 14():1329403. PubMed ID: 38288112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.
    Rosti V; Tremml G; Soares V; Pandolfi PP; Luzzatto L; Bessler M
    J Clin Invest; 1997 Sep; 100(5):1028-36. PubMed ID: 9276719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1 - clinical utility.
    Dezern AE; Borowitz MJ
    Cytometry B Clin Cytom; 2018 Jan; 94(1):16-22. PubMed ID: 29236352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology.
    Bessler M; Schaefer A; Keller P
    Transfus Med Rev; 2001 Oct; 15(4):255-67. PubMed ID: 11668433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
    Kawagoe K; Kitamura D; Okabe M; Taniuchi I; Ikawa M; Watanabe T; Kinoshita T; Takeda J
    Blood; 1996 May; 87(9):3600-6. PubMed ID: 8611683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of paroxysmal nocturnal hemoglobinuria].
    Murakami Y
    Rinsho Ketsueki; 2016; 57(10):1900-1907. PubMed ID: 27725586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
    Nishimura Ji ; Phillips KL; Ware RE; Hall S; Wilson L; Gentry TL; Howard TA; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse WF; Smith CA
    Blood; 2001 May; 97(10):3004-10. PubMed ID: 11342424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
    Kawaguchi T; Nakakuma H
    Int J Hematol; 2007 Jul; 86(1):27-32. PubMed ID: 17675263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glycosylphosphatidylinositol anchor and paroxysmal nocturnal haemoglobinuria/aplasia model.
    Hall C; Richards SJ; Hillmen P
    Acta Haematol; 2002; 108(4):219-30. PubMed ID: 12432218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations and clonal expansions in paroxysmal nocturnal hemoglobinuria.
    Hosokawa K; Nakao S
    Semin Hematol; 2022 Jul; 59(3):143-149. PubMed ID: 36115691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria in children.
    van den Heuvel-Eibrink MM
    Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of paroxysmal nocturnal hemoglobinuria.
    Inoue N; Murakami Y; Kinoshita T
    Int J Hematol; 2003 Feb; 77(2):107-12. PubMed ID: 12627844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal Cell Proliferation in Paroxysmal Nocturnal Hemoglobinuria: Evaluation of
    Park J; Kim M; Kim Y; Han K; Chung NG; Cho B; Lee SE; Lee JW
    Ann Lab Med; 2019 Sep; 39(5):438-446. PubMed ID: 31037862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.